Biotechnology Research in Space Shifts to Manufacturing
Biotechnology efforts aboard the Starlab space station are reportedly shifting from pure research to commercial manufacturing. Key projects include LambdaVision's work on artificial retinas, the Auxilium 3D bio-printer, and Helogen's DNA sequencing technology. This transition indicates a move toward producing advanced materials and medical products in a microgravity environment.
Starlab, a joint venture between Voyager Space and Airbus, is slated for launch as early as 2028 to ensure a continued human presence in low-Earth orbit as the International Space Station (ISS) approaches retirement. The station is designed to be launched in a single mission aboard a SpaceX Starship, becoming fully operational within weeks and eliminating the need for on-orbit assembly. The microgravity environment of space offers unique advantages for manufacturing, as the absence of gravity-related forces like sedimentation and convection allows for the creation of more perfect and uniform structures. This is particularly beneficial for creating protein-based artificial retinas, where layers of the light-activated protein bacteriorhodopsin can be applied with greater precision. LambdaVision has already conducted nine missions to the ISS to refine its manufacturing process. Auxilium's AMP-1 3D bioprinter has demonstrated the ability to mass-produce complex structures like perfusable blood vessels in microgravity, a process not feasible on Earth. This technology is seen as a stepping stone to producing the next generation of life science technologies in space. On a recent six-week mission, the AMP-1 printed eight implantable medical devices to repair peripheral nerve damage in just two hours. The ability to sequence DNA in space, first accomplished by NASA astronaut Kate Rubins in 2016, is critical for diagnosing illnesses and identifying microbes on long-duration missions. Helogen's HEL-IOS™ system aims to automate the entire process of biological cultivation, processing, sequencing, and analytics, transforming Starlab from a laboratory into a scalable production facility without the need for constant crew intervention.
